Boiron SA (EPA:BOI)

Market Cap	432.32M
Revenue (ttm)	481.71M
Net Income (ttm)	23.69M
Shares Out	17.36M
EPS (ttm)	1.36
PE Ratio	18.25
Forward PE	21.96
Dividend	1.35 (5.42%)
Ex-Dividend Date	n/a

Volume	611
Average Volume	5,224
Open	24.95
Previous Close	25.20
Day's Range	24.05 - 25.00
52-Week Range	22.90 - 36.35
Beta	0.42
RSI	54.21
Earnings Date	Mar 20, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,810
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2023, Boiron's revenue was 493.25 million, a decrease of -7.67% compared to the previous year's 534.24 million. Earnings were 35.83 million, a decrease of -19.80%.